Cargando…

Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia

Many blood-based gene expression biomarkers for monitoring tuberculosis (TB) treatment have been suggested so far, but promising biomarker results for drug-resistant TB treatment response have not been studied. This protocol presents a prospective observational study in Indonesia to profile the huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Parwati, Ida, Pitaloka, Dian Ayu Eka, Chaidir, Lidya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698426/
https://www.ncbi.nlm.nih.gov/pubmed/36355869
http://dx.doi.org/10.3390/tropicalmed7110326
_version_ 1784838814136532992
author Parwati, Ida
Pitaloka, Dian Ayu Eka
Chaidir, Lidya
author_facet Parwati, Ida
Pitaloka, Dian Ayu Eka
Chaidir, Lidya
author_sort Parwati, Ida
collection PubMed
description Many blood-based gene expression biomarkers for monitoring tuberculosis (TB) treatment have been suggested so far, but promising biomarker results for drug-resistant TB treatment response have not been studied. This protocol presents a prospective observational study in Indonesia to profile the human blood transcriptome for predicting the response to drug-resistant TB treatment, focusing on pulmonary TB, and to adapt the specific RNA signature to the qRT-PCR platform. Longitudinal blood samples will be collected from 44 subjects with rifampicin resistant TB, confirmed by Xpert MTB/RIF, and 52 healthy controls. RNA-Seq will be performed to identify changes in the transcriptome following TB treatment. A discriminative RNA signature will be chosen and translated into a score for use in a quantitative PCR-based assay. This study will provide crucial information to guide the discovery and design of a clinically implementable tool to monitor the response of TB treatment.
format Online
Article
Text
id pubmed-9698426
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96984262022-11-26 Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia Parwati, Ida Pitaloka, Dian Ayu Eka Chaidir, Lidya Trop Med Infect Dis Protocol Many blood-based gene expression biomarkers for monitoring tuberculosis (TB) treatment have been suggested so far, but promising biomarker results for drug-resistant TB treatment response have not been studied. This protocol presents a prospective observational study in Indonesia to profile the human blood transcriptome for predicting the response to drug-resistant TB treatment, focusing on pulmonary TB, and to adapt the specific RNA signature to the qRT-PCR platform. Longitudinal blood samples will be collected from 44 subjects with rifampicin resistant TB, confirmed by Xpert MTB/RIF, and 52 healthy controls. RNA-Seq will be performed to identify changes in the transcriptome following TB treatment. A discriminative RNA signature will be chosen and translated into a score for use in a quantitative PCR-based assay. This study will provide crucial information to guide the discovery and design of a clinically implementable tool to monitor the response of TB treatment. MDPI 2022-10-22 /pmc/articles/PMC9698426/ /pubmed/36355869 http://dx.doi.org/10.3390/tropicalmed7110326 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Protocol
Parwati, Ida
Pitaloka, Dian Ayu Eka
Chaidir, Lidya
Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia
title Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia
title_full Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia
title_fullStr Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia
title_full_unstemmed Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia
title_short Transcriptional Biomarkers for Treatment Monitoring of Pulmonary Drug-Resistant Tuberculosis: Protocol for a Prospective Observational Study in Indonesia
title_sort transcriptional biomarkers for treatment monitoring of pulmonary drug-resistant tuberculosis: protocol for a prospective observational study in indonesia
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698426/
https://www.ncbi.nlm.nih.gov/pubmed/36355869
http://dx.doi.org/10.3390/tropicalmed7110326
work_keys_str_mv AT parwatiida transcriptionalbiomarkersfortreatmentmonitoringofpulmonarydrugresistanttuberculosisprotocolforaprospectiveobservationalstudyinindonesia
AT pitalokadianayueka transcriptionalbiomarkersfortreatmentmonitoringofpulmonarydrugresistanttuberculosisprotocolforaprospectiveobservationalstudyinindonesia
AT chaidirlidya transcriptionalbiomarkersfortreatmentmonitoringofpulmonarydrugresistanttuberculosisprotocolforaprospectiveobservationalstudyinindonesia